Article
The partial erythropoietin receptor agonist ML1-R is a potent neuroprotective drug with a distinct signaling profile.
2025-01-08
Abstract excerpt
<title>Abstract</title> <p>Erythropoietin (EPO) is a glycoprotein that stimulates red blood cell production in the bone marrow and protects neurons from oxidative stress, making it a potential treatment for various neurological diseases. However, EPO analogs often lead to side effects like excessive erythropoiesis and tumor growth. In this study, we aimed to develop ML1-R, a peptide derived from the C-helix of EP...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 867c5b4a-ef55-5381-8002-01b5768a2d9d
- DOI
- 10.21203/rs.3.rs-5779616/v1
